"We are the premier cardiology group serving the East Bay. We offer the latest in cardiology services, including diagnostic testing and non-surgical approaches."

During the past decade, Cardiovascular Consultants Medical Group conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Cardiovascular Consultants Medical Group" #1 sponsor was "Otsuka Pharmaceutical Development & Commercialization, Inc." with 2 trials, followed by "Advanz Pharma" with 1 trials sponsored, "Cardiovascular Clinical Studies" with 1 trials sponsored, "Titan Pharmaceuticals" with 1 trials sponsored and "Vicor Technologies, Inc." with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Cardiovascular Consultants Medical Group" #1 collaborator was "GlaxoSmithKline" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Cardiovascular Consultants Medical Group" are "Congestive Heart Failure" (2 trials), "Atrial Fibrillation" (1 trials), "Cardiac Sudden Death" (1 trials), "Chronic Heart Failure" (1 trials) and "Heart Failure, Congestive" (1 trials). Many other conditions were trialed in "Cardiovascular Consultants Medical Group" in a lesser frequency.

Most popular intervention types in "Cardiovascular Consultants Medical Group" are "Drug" (5 trials). Other intervention types were less common.

The name of intervention was led by "Tolvaptan" (2 trials), "DITPA (3,5-diiodothyropropionic acid)" (1 trials), "Placebo" (1 trials), "Placebo comparator" (1 trials) and "Vernakalant (oral)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Cardiovascular Consultants Medical Group" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Cardiovascular Consultants Medical Group". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Cardiovascular Consultants Medical Group, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Cardiovascular Consultants Medical Group, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".